Adam S Grossman sold $338k of ADMA
President and CEO at ADMA BIOLOGICS, INC.. 21,000 shares at an average of $16.08, traded Feb 17, 2026, filed Feb 17, 2026.
Score components
- +25RoleCEO
- +15Trade size$338k at market
- 0Share of holdings soldSold 0.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.8%, 3m -45.9%, 6m -40.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-005888, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,305,379 | Feb 17, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.08 | $241k | 2,290,379 | Feb 17, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.08 | $96k | 2,284,379 | Feb 17, 2026 |
| Feb 17, 2026 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 705,950 | Feb 17, 2026 |
Related signals
Other insiders at ADMA BIOLOGICS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $51k 6,400 shares | +1% | |
| 48Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $100k 12,500 shares | +2% | |
| 43Moderate | ADMAbuy ADMA BIOLOGICS, INC. | Jerrold B Grossman director | $100k 12,500 shares | +3% | |
| 12Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $318k 21,000 shares | -1% | |
| 24Weak | ADMA BIOLOGICS, INC. | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | $158k 10,096 shares | -2% | |
| 30Weak | ADMAbuy ADMA BIOLOGICS, INC. | Steve Elms director | $217k 14,000 shares | +1% | |
| 6Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $416k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $336k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $336k 21,000 shares | -1% | |
| 5Weak | ADMA BIOLOGICS, INC. | Adam S Grossman President and CEO | $339k 21,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.